Autism, gut-blood-brain barrier, and mast cells.

@article{Theoharides2008AutismGB,
  title={Autism, gut-blood-brain barrier, and mast cells.},
  author={Theoharis C. Theoharides and Robert L. Doyle},
  journal={Journal of clinical psychopharmacology},
  year={2008},
  volume={28 5},
  pages={
          479-83
        }
}
Autism and autism spectrum disorders (ASDs) are pervasive neurodevelopmental disorders diagnosed in early childhood. They are characterized by varying degrees of dysfunctional communication and social skills, as well as repetitive and stereotypical behaviors. The diagnosis has increased considerably over the last few years, but it is not clear whether higher prevalence of the disorder, improved awareness by clinicians, or a combination of these is responsible. Autism spectrum disorder onsets in… Expand
Autism Spectrum Disorders and Mastocytosis
  • T. Theoharides
  • Medicine
  • International journal of immunopathology and pharmacology
  • 2009
TLDR
It is reported that the apparent prevalence of ASD in patients with mastocytosis, a rare disease occuring in 1/4,000 children and characterized by an increased number of hypersensitive mast cells in many organs, is about 1/10 or 10 times higher than the general population. Expand
Autism: an emerging ‘neuroimmune disorder’ in search of therapy
TLDR
Recent publications on ASDs pathogenesis and treatment with emphasis on neuroimmune processes and new therapeutic approaches are reviewed, finding increased oxidative stress and immune dysregulation are present in ASDs. Expand
Perinatal stress, brain inflammation and risk of autism-Review and proposal
TLDR
Premature birth and susceptibility genes may make infants more vulnerable to allergic, environmental, infectious, or stress-related triggers that could stimulate mast cell release of pro-inflammatory and neurotoxic molecules, thus contributing to brain inflammation and ASD pathogenesis, at least in an endophenotype of ASD patients. Expand
Autism and Immunity: Revisited Study
TLDR
In conclusion, mast cell activation could contribute to immune and neuroinflammatory abnormalities that are evident in patients with autism spectrum disorders. Expand
Mast Cells, Stress, Fear and Autism Spectrum Disorder
TLDR
The combination of corticotropin-releasing hormone (CRH), secreted under stress, together with environmental stimuli could be major contributors to the pathogenesis of ASD. Expand
Focal brain inflammation and autism
TLDR
The phosphatase and tensin homolog (PTEN) gene mutation, associated with the higher risk of ASD, which leads to hyper-active mammalian target of rapamycin (mTOR) signalling that is crucial for cellular homeostasis, could hyperstimulate the already activated mTOR, as well as stimulate mast cell and microglia activation and proliferation. Expand
Perinatal Immune Activation and Risk of Autism
He could fit in the palms of both hands, seemed to look at you beseechingly while you rushed to thread a vein and snake a tube down a tiny nostril of this 24 week preemie. Already exposed to theExpand
Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders
TLDR
Lack of microglial phagocytosis and decreased levels of BDNF appear to distinguish Rett syndrome from ASDs, in which there is instead microglia activation and/or proliferation and possibly defective BDNF signaling. Expand
Unwanted interactions among psychotropic drugs and other treatments for autism spectrum disorders.
A utism spectrum disorders (ASD) are pervasive neurodevelopmental disorders affecting approximately 1% of children and characterized by varying degrees of deficiencies in social interactions,Expand
Autism Spectrum Disorder, Fear Response, and Environmental Exposures
TLDR
It is proposed that environmental stimuli stimulate the unique immune cells, known as mast cells (MC), which then trigger microglia, leading to dysfunctional neuronal connectivity in the amygdala, which lowers the “fear response” and leads to an exaggerated “fight-or-flight” reaction. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 99 REFERENCES
Novel therapeutic targets for autism.
TLDR
It is presented the opinion that non-allergic activation of gastrointestinal and brain mast cells could contribute to many of the pathologic findings and provide unique targets for ASD therapy. Expand
The immune response in autism: a new frontier for autism research
TLDR
This review will examine the status of the research linking the immune response with ASD and the potential that aberrant immune activity during vulnerable and critical periods of neurodevelopment could participate in the generation of neurological dysfunction characteristic of ASD. Expand
Immunity, neuroglia and neuroinflammation in autism
TLDR
The presence of neuroglial and innate neuroimmune system activation in brain tissue and cerebrospinal fluid of patients with autism is demonstrated, findings that support the view that neuroimmune abnormalities occur in the brain of autistic patients and may contribute to the diversity of the autistic phenotypes. Expand
Macrophage Migration Inhibitory Factor and Autism Spectrum Disorders
TLDR
These results identify MIF as a possible susceptibility gene for autism spectrum disorder and the precise relationship between MIF and the behavioral components of autistic spectrum disorder is unclear. Expand
Intestinal Pathophysiology in Autism
  • J. F. White
  • Biology, Medicine
  • Experimental biology and medicine
  • 2003
TLDR
The pathology, reported to extend from the esophagus to the colon, is described here along with other studies pointing to a connection between diet and the severity of symptoms expressed in autism. Expand
Dysregulated Innate Immune Responses in Young Children with Autism Spectrum Disorders: Their Relationship to Gastrointestinal Symptoms and Dietary Intervention
TLDR
Findings indicate intrinsic defects of innate immune responses in GI(+) ASD children but not in NFH or GI(–) ASD children, suggesting a possible link between GI and behavioral symptoms mediated by innate immune abnormalities. Expand
Intestinal cytokines in children with pervasive developmental disorders
OBJECTIVE:A relationship between autism and gastrointestinal (GI) immune dysregulation has been postulated based on incidence of GI complaints as well as macroscopically observed lymphonodularExpand
Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism
  • S. Jill James, S. Melnyk, +9 authors D. Gaylor
  • Biology, Medicine
  • American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2006
TLDR
It is proposed that an increased vulnerability to oxidative stress (endogenous or environmental) may contribute to the development and clinical manifestations of autism. Expand
Identification and Evaluation of Children With Autism Spectrum Disorders
TLDR
This report addresses background information, including definition, history, epidemiology, diagnostic criteria, early signs, neuropathologic aspects, and etiologic possibilities in autism spectrum disorders, and provides an algorithm to help the pediatrician develop a strategy for early identification of children with autism Spectrum disorders. Expand
Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism.
TLDR
An increased vulnerability to oxidative stress and a decreased capacity for methylation may contribute to the development and clinical manifestation of autism. Expand
...
1
2
3
4
5
...